Enable Biosciences
Peter Robinson is a co-founder and Chief Scientific Officer at Enable Biosciences, where responsibilities include the commercialization of ultrasensitive antibody assays for infectious and autoimmune diseases. Robinson has secured approximately $4.5 million in grants for developing assays aimed at early disease detection and treatment. Previous experience includes serving as a Graduate Student Researcher at Stanford University, collaborating with Carolyn Bertozzi, filing three patents, publishing six papers, and starting a company recognized with multiple awards. Educational qualifications include a Ph.D. in Chemistry and Chemical Biology from the University of California, Berkeley, and additional degrees from Stanford University and Baylor University.
This person is not in any offices
Enable Biosciences
Enable Biosciences is a South San Francisco-based diagnostics company. They develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases.